JW (CAYMAN) THERAPEUTICS CO. LTDJW (CAYMAN) THERAPEUTICS CO. LTDJW (CAYMAN) THERAPEUTICS CO. LTD

JW (CAYMAN) THERAPEUTICS CO. LTD

No trades
See on Supercharts

Price target

2.400.000.00%
The 1 analyst offering 1 year price forecasts for 2126 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to 2126 in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


2126 EPS for the last quarter is −0.62 HKD despite the estimation of −0.69 HKD. In the next quarter EPS is expected to reach −0.70 HKD. Track more of JW (CAYMAN) THERAPEUTICS CO. LTD financials and stay on top of what is up with the company.
In the next quarter JW (CAYMAN) THERAPEUTICS CO. LTD revenue is expected to reach ‪140.19 M‬ HKD. Check out JW (CAYMAN) THERAPEUTICS CO. LTD revenue and earnings and make informed decisions.
According to analysts, 2126 price target is 2.40 HKD with a max estimate of 2.40 HKD and a min estimate of 2.40 HKD. Check if this forecast comes true in a year, meanwhile watch JW (CAYMAN) THERAPEUTICS CO. LTD stock price chart and keep track of the current situation with 2126 news and stock market news.